We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Suggests Alternatives for Demonstrating CGMP Compliance for Combination Products
FDA Suggests Alternatives for Demonstrating CGMP Compliance for Combination Products
The FDA released a list of alternative suggestions for complying with CGMP requirements for drug combination products that covers stability testing, release for distribution, reserve samples and special testing requirements.